glp-1 ra medications found to be safe and effective for treating obesity in adults with mental illness Possible Link Between GLP-1 RA

PMID 16005476

J., Cardiovascular Effects of Dipeptidyl Peptidase4 Inhibitors: From Risk Factors to Clinical Outcomes, Postgraduate Medicine 125, no

These drugs' ability to help patients lose anywhere from 15% to 20% of body weight has made them one of the most powerful nonsurgical obesity treatments ever seen

In addition to helping with insulin resistance, these medications can benefit those with PCOS in other ways: by promoting weight loss, regulating menstrual cycles, reducing chronic inflammation, and lowering the risk of cardiovascular disease and non-alcoholic fatty liver disease, conditions that can be associated with PCOS

I think 80% of the revenues come from consumables but they saw a 40% drop in share price for not really any good reason other than some weakness and the market saw that and pounced, claiming that perhaps the GLP-1s out there are creating some problems for companies that help treat diabetes, right